Episode Details

Back to Episodes
Episode 288: April 2021 Preview Retinal Physician Preview Including Discussion of Complement Pathways for Dry AMD, Brolucizumab Real World Outcomes, Clinical Trial Adjustments with COVID-19, and Polypoidal Choroidal Vasculopathy

Episode 288: April 2021 Preview Retinal Physician Preview Including Discussion of Complement Pathways for Dry AMD, Brolucizumab Real World Outcomes, Clinical Trial Adjustments with COVID-19, and Polypoidal Choroidal Vasculopathy

Published 5 years, 2 months ago
Description

Drs. Mrinali Gupta and Ajay Kuriyan join for a group discussion of the April 2021 edition of Retinal Physician with a focus on macular degeneration and clinical trials.

\Relevant financial Disclosures: Dr. Gupta is a consultant for Allergan. Dr. Kuriyan is a consultant for Genentech, Regeneron, and Allergan and has received grant support from Genentech. Dr. Sridhar is a consultant for Regeneron and a unmasked treating physician for an Apellis trial.

Listen Now

Love PodBriefly?

If you like Podbriefly.com, please consider donating to support the ongoing development.

Support Us